Recently, I've seen a number of patients for new #HIV diagnoses that have described frustrating experiences of trying to obtain #PrEP.
One patient said when he finally worked up the courage to ask his PCP about starting PrEP, he was told to "just use condoms."
1/
In collaboration with @UKHSA our study on genomic epidemiology #Syphilis is now out @LancetMicrobeshorturl.at/jnvS1 We found evidence for separation of sub-lineages by HIV status & sexual orientation consistent with distinct sexual networks 1/n
Our meta-analysis of #HCV in #PrEP users now available open access in @OFIDJournal. We found lower HCV incidence in contexts where HCV #DAAs have been implemented at-scale - indicative of HCV treatment as prevention among gay and bisexual men.
Incidence and prevalence of hepatitis C virus among HIV-negative gay and bisexual men using HIV pre-exposure prophylaxis (PrEP): a systematic review and meta-analysis
✅ Just Accepted
🔓 Open Access
🔗 bit.ly/43NnDjb
#PrEP is a powerful tool for #HIV prevention
Still, too many barriers to PrEP exist for too many people. Sometimes, the barriers are medical providers
Improving access to PrEP is critical. Greatly appreciate @juanmichaelii for discussing a few (of the many) ways to ⬇️ barriers
🔈 Opening soon! Antimicrobial Resistance 2024! #AMR2024
Join us to explore the importance of genomic data for tackling #AntimicrobialResistance🔬🧬🦠💪🏾
Email us to receive e-updates about this conference: 📩conferences@wellcomeconnectingscience.org
#AcademicChatter#PhDlife
ALT Wellcome Connecting Science logo (top left)
Delegates seated in the Hinxton Hall Conference Centre Auditorium, facing a speaker on the stage. Some of the delegates have laptops open and are typing notes from the lecture.
Text reads: Antimicrobial Resistance: Genome, Big Data and Emerging Technologies (hybrid conference)
Conference dates: 13-15 March 2024
Location: Hinxton Hall Conference Centre, Wellcome Genome Campus, UK and online.
Save the date!
Our team at @GaDPH is excited to announce that effective 8/14/2023, care providers will be able to prescribe Hepatitis C medications for their patients under ADAP without the need for Prior Approval @CarlosdelRio7 @Armstrws @drmt @DavidHollandMD @DocWoc71 @JColasantiMD
Many states have done a good job of reducing barriers to Hep C treatment; yet only 20% treated within 6 months; 35% overall. Providers must ensure newly get treated. Why don’t they?
2 states still require Medicaid enrollees to have liver scarring before they can be cured of Hepatitis C. Akin to requiring cancer to metastasize before allowing surgery
From "Hepatitis C: State of Medicaid Access" / Harvard law school
stateofhepc.org/2023-nationa…
#PrEP reduces anxiety, increases intimacy and leads to more pleasurable sex, but these values-based outcomes are neglected in PrEP resources. In @TheLancetHIV we argue for better integration of potential user-reported benefits in PrEP training & guidelines authors.elsevier.com/a/1hZac…
Our latest newsletter focuses on sexual health in older adults, including the @shoar_uk project which explores sexual health needs among older adults, including those with disabilities.
Read the newsletter and subscribe here:
us19.campaign-archive.com/ho…
ALT Close up of two people's hands clasped together with text reading "sexual health in older adults research: Participatory and community driven research to obtain evidence for improving sexual health services among older adults"
👉Isolated cases of pharyngeal gonorrhoea resistant to both ceftriaxone and azithromycin reported in the UK since 2016.
👉these cases are likely to be the tip of the global iceberg detected due to stringent surveillance and treatment protocols in the UK 👏
@DewsnapClaire
NEW: briefing on #Gonorrhoea. Thanks to @aidsmap for producing this resource with an overview of gonorrhoea epidemiology in England, antibiotic resistance, and the implications for #HIVprevention and services.
Read and download it here:
hivpreventionengland.org.uk/…
#GlobalHealth Fellowship alert! 📣 Fulbright-Fogarty Fellowships in Public Health open to advanced medical and Ph.D. students interested in global health.
Info: go.nih.gov/FulbrightFogarty
Deadline: October 10, 2023
@FulbrightPrgrm
ALT Application deadline: Fulbright-Fogarty Fellowships in Public Health. Due: October 10, 2023. Fogarty International Center at NIH.
Misdiagnosis of bacterial pneumonia increases risk of exposure to inappropriate antibiotics and adverse events!
The authors developed a diagnosis calculator* to inform clinical diagnosis of community-acquired bacterial pneumonia #IDXposts#CAPcambridge.org/core/journals/…
Nice to see some @UCLA_Pathology#ClinicMicro group here!
They've been working to build #NGS pipelines at the lab and also doing some great teaching on #WGS and #genomics analyses. @UCLA_ID
Happening right now (but you can watch the recording later) an excellent @ASMicrobiology clin micro virtual journal club. Predicting antimicrobial resistance by NGS (E. coli-cefepime & non-TB AFB) is an exciting & developing area (but some caveats apply!) pathlms.com/asm/courses/3961…
Officially re-releasing our Infections in Immunocompromised Hosts schema for the new academic year!!
What does it mean to be “immunocompromised?”
Check it out below!!!
👇👇👇
@Cortes_Penfield @transplantID @EvaAmenta @KatieBedardMD
Spent today at the Hospital for Dermatology & Venereology in Ho Chi Minh City 🇻🇳 and came across this 50 pack of benzathine #penicillin used to treat #syphilis
Cost: ~$4 USD/dose
Team was shocked to learn a) we're having shortages in US & b) price is 150x higher 🤯
I agree!